CLK4 and esophageal squamous cell carcinoma: It was observed that the reintroduction of CLK4‐M307Q in CLK4 knockdown ESCC cells significantly enhanced cell proliferation and tumor growth in xenograft experiments as compared with the CLK4‐M307T group (Figure 11Di,ii).